Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts 2022-05-25 23:04
The Centre for Probe Development and Commercialization expands into Asia and executes a development, manufacturing, and clinical supply agreement for 177Lu-PSMA (DGUL) With South Korea-based CellBion 2022-05-25 21:00
SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit 2022-05-25 20:30
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic 2022-05-25 19:00
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody 2022-05-25 17:42
CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions 2022-05-25 07:00
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment 2022-05-25 05:00
ICP DAS - BMP will attend Medical Taiwan Expo 2022 in Taipei 2022-05-25 01:25
Eurofins Discovery Announces Formation of its New Scientific Advisory Board 2022-05-24 23:00
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment 2022-05-24 21:00
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention 2022-05-24 20:00
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis 2022-05-24 19:00
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis 2022-05-24 19:00
KAZIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES HOSTED BY HC WAINWRIGHT AND LD MICRO 2022-05-23 20:30
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand 2022-05-23 20:28
Antengene Announces First Patient Dosed in the Phase I/II SWATCH Study of XPOVIO® (Selinexor) for the Treatment of B-Cell Non-Hodgkin Lymphomas 2022-05-23 10:10
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma 2022-05-21 01:19
Lipidor updates on Phase III study of AKP02 in treatment of psoriasis - half of patients now recruited 2022-05-20 14:56
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-05-19 22:39
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays 2022-05-19 20:30
1 135 136 137 138 139 413